According to the UnivDatos, the surge in the incidence of AMD population and the rise in demand for innovative therapies will drive the global scenario of Age-related Macular Degeneration. As per their “Age-related Macular Degeneration Market” report, the global market was valued at USD 11 billion in 2023, growing at a CAGR of about 7.5% during the forecast period from 2024 - 2032...